Nova Cannabis Inc. (NVACF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Nova Cannabis Inc. (NVACF) trades at $1.26. Nova Cannabis Inc. operates retail cannabis stores in Canada, focusing on the recreational-use market. As a subsidiary of Alcanna Inc. Market cap: $78.47M, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for NVACF: NVACF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NVACF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NVACF: 1/1 perspectives are bearish.
How is this calculated? →Nova Cannabis Inc. (NVACF) Healthcare & Pipeline Overview
Nova Cannabis Inc. operates retail cannabis stores in the Canadian recreational cannabis market, with 78 locations across Alberta, Ontario, and Saskatchewan as of March 2022. As a subsidiary of Alcanna Inc., the company focuses on providing a diverse range of cannabis products to adult consumers.
What Is the Investment Thesis for NVACF?
Nova Cannabis Inc. presents a focused play on the Canadian recreational cannabis market. The company's expansion strategy, with 78 stores as of March 2022, positions it to capture a share of the growing cannabis retail sector. A key value driver is the potential for increased same-store sales as the market matures and consumer acceptance grows. The company's current P/E ratio of 32.9 reflects investor expectations of future earnings growth. However, the company's low profit margin of 1.2% and gross margin of 19.4% indicate potential challenges in achieving profitability. The negative beta of -2.06 suggests the stock moves inversely to the market. Investors should monitor regulatory changes and competitive pressures within the Canadian cannabis market.
Based on FMP financials and quantitative analysis
NVACF Key Highlights
- Operates 78 cannabis stores in Alberta, Ontario, and Saskatchewan as of March 31, 2022, providing a significant retail footprint in key Canadian markets.
- Subsidiary of Alcanna Inc., offering potential access to resources and expertise.
- Focus on the recreational-use cannabis market in Canada, positioning the company to capitalize on the growing demand for legal cannabis products.
- Profit margin of 1.2% indicates potential for improvement in operational efficiency and cost management.
- Gross margin of 19.4% reflects the difference between revenue and the cost of goods sold, highlighting the need to optimize pricing and supply chain management.
Who Are NVACF's Competitors?
NVACF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BIOGF Biocartis Group N.V. | $0.66 | -85.33% | $65.41M | 52 |
| CKMTF Carmat S.A. | $12.75 | -50.96% | $85.19M | 61 |
| EOFBY Ecofibre Limited | $0.84 | +0.00% | $73.67M | 40 |
| ETXPF E-therapeutics Plc | $0.13 | +0.00% | $75.96M | 38 |
| ATAI Atai Beckley NV is a clinical-stage biopharmaceutical company focused on developing treatments for mental health disorders. The company | $4.88 | -5.97% | $1.80B | 68 |
| MEDS TRxADE HEALTH, Inc. | $7.59 | +4.55% | $13.28M | 63 |
| ONC BeOne Medicines Ltd. | $309.46 | +3.97% | $33.07B | 61 |
| NEUP Neuphoria Therapeutics Inc. | $3.44 | +1.78% | $18.59M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NVACF's Key Strengths?
- Established retail presence in Alberta, Ontario, and Saskatchewan.
- Focus on the recreational-use cannabis market.
- Relationship with Alcanna Inc.
- Operates 78 stores as of March 2022.
What Are NVACF's Weaknesses?
- Low profit margin of 1.2%.
- Gross margin of 19.4%.
- Limited geographic presence compared to larger competitors.
- Dependence on regulatory environment in Canada.
What Could Drive NVACF Stock Higher?
- Potential regulatory changes in Canadian provinces could open new markets for Nova Cannabis.
- Expansion of retail footprint in existing markets.
- Development and launch of new cannabis products.
- Strategic partnerships or acquisitions to expand market reach.
What Are the Key Risks for NVACF?
- Inconsistent delivery — missed Wall Street EPS estimates in 3 of the last 4 reported quarters.
- Rich valuation — a P/E of 32.9 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Increasing competition from other cannabis retailers.
- Changing regulations and government policies.
- Fluctuations in cannabis prices and demand.
- Oversupply in the Canadian cannabis market.
- Limited liquidity due to OTC market trading.
What Are the Growth Opportunities for NVACF?
- Expansion into New Provinces: Nova Cannabis has the opportunity to expand its retail footprint into additional Canadian provinces as regulations evolve. This would allow the company to reach new customers and increase its overall market share. The timeline for expansion depends on regulatory approvals and market conditions in each province. The addressable market size would vary depending on the population and cannabis consumption patterns in each new region.
- E-commerce Platform Development: Developing a robust e-commerce platform would enable Nova Cannabis to reach customers beyond its physical store locations. This would provide convenience for customers and expand the company's sales channels. The timeline for launching an e-commerce platform is estimated at 12-18 months, with ongoing investment in technology and marketing. The potential market size includes all Canadian adults who prefer online shopping for cannabis products.
- Product Innovation and Diversification: Nova Cannabis can drive growth by introducing new and innovative cannabis products to its stores. This could include edibles, beverages, concentrates, and other specialized products. The timeline for product development and launch varies depending on the complexity of the product and regulatory requirements. The addressable market size depends on consumer demand for specific product categories.
- Strategic Partnerships and Acquisitions: Nova Cannabis could pursue strategic partnerships or acquisitions to expand its market reach and product offerings. This could involve partnering with other cannabis companies or acquiring smaller retailers. The timeline for partnerships and acquisitions depends on due diligence and negotiation processes. The potential market size would depend on the scope and scale of the partnerships or acquisitions.
- Loyalty Program Implementation: Implementing a customer loyalty program would help Nova Cannabis retain existing customers and attract new ones. This would involve offering rewards and incentives for repeat purchases. The timeline for launching a loyalty program is estimated at 6-9 months, with ongoing investment in marketing and customer service. The potential market size includes all existing and potential customers who are motivated by loyalty rewards.
What Opportunities Does NVACF Have?
- Expansion into new Canadian provinces.
- Development of an e-commerce platform.
- Product innovation and diversification.
- Strategic partnerships and acquisitions.
What Threats Does NVACF Face?
- Increasing competition from other cannabis retailers.
- Changing regulations and government policies.
- Fluctuations in cannabis prices and demand.
- Potential for oversupply in the Canadian cannabis market.
What Are NVACF's Competitive Advantages?
- Established retail presence in key Canadian markets.
- Relationship with Alcanna Inc. providing access to resources.
- Focus on the recreational-use cannabis market.
What Does NVACF Do?
Nova Cannabis Inc. is a Canadian-based company focused on the retail sale of recreational cannabis. The company operates a chain of cannabis stores across Alberta, Ontario, and Saskatchewan. As of March 31, 2022, Nova Cannabis operated 78 stores. Nova Cannabis is a subsidiary of Alcanna Inc. The company's stores offer a variety of cannabis products, including dried flower, oils, edibles, and accessories. Nova Cannabis aims to provide a safe and informative shopping experience for adult consumers interested in exploring cannabis products. The company is committed to complying with all applicable laws and regulations governing the sale of cannabis in Canada. Nova Cannabis continues to expand its retail footprint and product offerings to meet the evolving needs of the Canadian cannabis market.
What Products and Services Does NVACF Offer?
- Operates retail cannabis stores in Canada.
- Focuses on the recreational-use cannabis market.
- Sells a variety of cannabis products, including dried flower, oils, and edibles.
- Provides a retail experience for adult consumers.
- Complies with all applicable laws and regulations governing the sale of cannabis.
- Expands retail footprint in Alberta, Ontario, and Saskatchewan.
How Does NVACF Make Money?
- Generates revenue through the retail sale of cannabis products.
- Operates physical stores in key Canadian markets.
- Focuses on providing a diverse range of cannabis products to adult consumers.
What Industry Does NVACF Operate In?
The Canadian cannabis market has experienced significant growth since legalization in 2018. Nova Cannabis Inc. operates within this evolving landscape, competing with other licensed retailers and facing regulatory complexities. The market is characterized by increasing consumer demand, product innovation, and ongoing consolidation. Competitors include companies such as BIOGF (BioHarvest Sciences Inc.), CKMTF (Columbia Care Inc.), EOFBY (EnWave Corporation), ETXPF (Entourage Health Corp), and KIARF (Kiva Brands Inc.). Nova Cannabis's success depends on its ability to differentiate its retail experience, manage costs effectively, and adapt to changing regulations.
Who Are NVACF's Key Customers?
- Adult consumers in Canada who are legally allowed to purchase cannabis.
- Recreational cannabis users seeking a variety of products.
- Customers in Alberta, Ontario, and Saskatchewan.
Company Profile
Nova Cannabis Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Edmonton, CA. The company is led by CEO Grant Sanderson. NVACF has traded publicly since 2021.
Nova Cannabis Inc. Financial Trajectory
Nova Cannabis Inc. (NVACF) reported $69.2M in revenue for Q2 2024, reflecting 7.7% growth compared to the prior quarter. The company recorded net income of $859K, with diluted EPS of $0.01.
How Nova Cannabis Inc. Is Valued
Nova Cannabis Inc. carries a market capitalization of $78.47M, placing it in the micro-cap category.
ROE 6%Key Financial Metrics
Return on equity for Nova Cannabis Inc. stands at 6.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.4%, showing how much profit it generates from its asset base. NVACF trades at a trailing price-to-earnings ratio of 32.88, above the Healthcare sector average of ~23x. Its free cash flow yield is 8.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.22 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.0%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 6/9Financial Health
Nova Cannabis Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.77 places it in the grey zone, a middle ground that warrants monitoring.
1/4 beatsEarnings Track Record
Nova Cannabis Inc. has missed Wall Street's EPS estimate in 3 of its last 4 reported quarters — a mixed record worth weighing. Reported results have landed about 55.3% below estimates on average.
FY2026 estForward Outlook
Wall Street analysts project Nova Cannabis Inc. revenue of about $373.8M for fiscal 2026, with EPS near $0.16.
NVACF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Nova Cannabis seems to be gaining some traction in the social trading community; recent discussions highlight a growing interest in the company's strategic partnerships and expansion plans.
- There's a perception that Nova Cannabis is undervalued compared to its peers, leading some to believe it has significant upside potential as the cannabis market matures.
- Insider activity suggests a positive outlook, with some community members interpreting recent moves as a sign of confidence in the company's future performance.
- The overall market sentiment appears to be shifting favorably, with more community members expressing optimism about Nova Cannabis's ability to capitalize on emerging opportunities in the cannabis sector.
Bear Case
- Despite the bullish sentiment, some traders are concerned about the competitive landscape and Nova Cannabis's ability to maintain its market share against larger, more established players.
- There's skepticism regarding the company's long-term profitability, with some community members questioning whether Nova Cannabis can achieve sustainable growth in a highly regulated and competitive industry.
- Recent discussions reveal concerns about potential regulatory changes that could negatively impact Nova Cannabis's operations and profitability.
- Some traders are wary of the company's financial stability, citing concerns about its debt levels and cash flow management in a challenging market environment.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2024 | $69M | $859,000 | $0.01 |
| Q1 2024 | $64M | -$333,000 | -$0.01 |
Based on FMP financials and quantitative analysis
NVACF Latest News
No recent news available for NVACF.
NVACF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NVACF.
Price Targets
Wall Street price target analysis for NVACF.
NVACF MoonshotScore
What does this score mean?
The MoonshotScore rates NVACF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Grant Sanderson
CEO
Grant Sanderson is the CEO of Nova Cannabis Inc. His background includes experience in retail management and operations. He has been involved in the cannabis industry for several years, focusing on building and scaling retail operations. His expertise includes strategic planning, financial management, and team leadership. He is responsible for overseeing all aspects of Nova Cannabis's business, including store operations, marketing, and product development. He is committed to driving growth and profitability for the company.
Track Record: Under Grant Sanderson's leadership, Nova Cannabis Inc. has expanded its retail footprint to 78 stores across Alberta, Ontario, and Saskatchewan. He has focused on building a strong team and implementing efficient operational processes. He has also overseen the development of new product offerings and marketing initiatives. His strategic decisions have contributed to the company's growth and market position.
NVACF OTC Market Information
The OTC Other tier represents the lowest tier of over-the-counter (OTC) securities. Companies in this tier may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. These securities are often speculative and carry a higher degree of risk compared to exchange-listed stocks on NYSE or NASDAQ due to less stringent listing standards and regulatory oversight. Investing in OTC Other stocks requires careful due diligence and an understanding of the associated risks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity can make it difficult to buy or sell shares at desired prices.
- Lack of regulatory oversight increases the risk of fraud or mismanagement.
- Limited financial disclosure makes it challenging to assess the company's financial health.
- Price volatility can lead to significant losses.
- OTC Other stocks are often speculative and carry a higher degree of risk.
- Verify the company's financial statements and reporting practices.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC Other stocks.
- Review the company's filings with regulatory agencies.
- Consult with a financial advisor before making any investment decisions.
- Operation of 78 retail stores suggests an established business.
- Subsidiary of Alcanna Inc. may provide some level of oversight.
- Focus on the regulated cannabis market indicates a commitment to compliance.
NVACF Healthcare Stock FAQ
What does Nova Cannabis Inc. do?
Nova Cannabis Inc. operates retail cannabis stores in Canada, focusing on the recreational-use market. The company offers a variety of cannabis products, including dried flower, oils, edibles, and accessories. As of March 31, 2022, Nova Cannabis operated 78 stores in Alberta, Ontario, and Saskatchewan. The company aims to provide a safe and informative shopping experience for adult consumers interested in exploring cannabis products. Nova Cannabis is a subsidiary of Alcanna Inc.
What are the main risks for NVACF?
The main risks for Nova Cannabis Inc. include increasing competition from other cannabis retailers, changing regulations and government policies, fluctuations in cannabis prices and demand, and the potential for oversupply in the Canadian cannabis market. Additionally, the company faces risks associated with operating in the OTC market, including limited liquidity and regulatory oversight. Investors should carefully consider these risks before investing in NVACF.
What are the key factors to evaluate for NVACF?
Evaluate NVACF on fundamentals, analyst consensus, and risk factors. P/E: 32.9x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does NVACF data refresh on this page?
NVACF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NVACF's recent stock price performance?
Nova Cannabis Inc. (NVACF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established retail presence in Alberta, Ontario, and Saskatchewan. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NVACF overvalued or undervalued right now?
Nova Cannabis Inc. (NVACF) trades at 32.9x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NVACF?
Before investing in Nova Cannabis Inc. (NVACF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding NVACF to a portfolio?
Key strength of Nova Cannabis Inc. (NVACF): Established retail presence in Alberta, Ontario, and Saskatchewan. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on information available as of 2022-03-31.
- AI analysis is pending and may provide further insights.